Equities

Republic Healthcare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Republic Healthcare Ltd

Actions
  • Price (HKD)0.188
  • Today's Change0.007 / 3.87%
  • Shares traded140.00k
  • 1 Year change+213.33%
  • Beta-0.4256
Data delayed at least 15 minutes, as of Mar 05 2026 07:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Republic Healthcare Limited is a Singapore-based investment holding company. The Company and its subsidiaries are principally engaged in operating the medical clinics business in Singapore and provision of management advisory services, and education related business. It operates a network of general practice clinics under the brand DTAP. The Company provides quality care services for a range of conditions, including sexual health, men’s health, and women’s health. The Company also operates an online healthcare lifestyle business under the brand name, Quinn. Its subsidiaries include Republic Healthcare Holdings Limited, Dtap Clinics Pte. Ltd., Quinn Healthcare Pte. Ltd., Vietnam Dtap Company Limited, and others.

  • Revenue in HKD (TTM)48.33m
  • Net income in HKD-7.61m
  • Incorporated2018
  • Employees34.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.